InsidersTradesSigma
Follow the NH농우바이오 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Food & Beverage sector, NH농우바이오 has published 4 public disclosures. Market capitalisation: €459bn. The latest transaction was filed on 17 March 2022 (Other). Among the most active insiders: NH농우바이오. The full history is free.
Analysts rate NH농우바이오 Strong Buy (bullish), based on 5 analysts. Average price target: ₩22,600.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
NH농우바이오 is a South Korean company specializing in the agro-food sector. It is listed on the XKRX market.